All News

A new study has confirmed that a genetic test that measures cell cycle progression (CCP) can be a useful tool for predicting which patients will have prostate cancer recurrence, especially when combined with existing information from laboratory and pathology tests.

The FDA has approved radium Ra 223 dichloride (Xofigo) injection for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases, and no known visceral metastatic disease.

Older prostate cancer patients with three or more underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by UCLA urologists.

The push to reform Medicare’s sustainable growth rate (SGR) formula continues in Washington, with support for SGR repeal coming from leading House of Representatives committees.

Saying it’s time to take the guesswork out of buying a legitimate drug online and combat counterfeiters, Pfizer has launched a prescription-fulfillment website for the phosphodiesterase type-5 inhibitor sildenafil citrate (Viagra).

The AUA and the American Society for Radiation Oncology (ASTRO) have released a joint guideline on radiation therapy after prostatectomy for patients with and without evidence of prostate cancer recurrence.

A new genomic test for prostate cancer appears to help predict whether men are more likely to harbor an aggressive form of the disease, report researchers from the University of California, San Francisco.

Urologists’ compensation for on call coverage compares favorably with that of some other specialties and exceeds family physicians’ compensation, according to a survey that shows a wide variation in on call compensation by specialty.

Building on previous research suggesting a cause-and-effect link between mental illness and urinary dysfunction, a new study finds that older men with two or more lower urinary tract symptoms are more likely to have recently had thoughts of suicide.

Cook Medical has launched what the company is calling a new cost-effective endoscopic option for urologists. The Flexor Vue Deflecting Endoscopic System is used during urologic procedures to access and visualize body cavities or organs.

Researchers are predicting that the number of urologists in the United States will fall sharply over the next 12 years, dropping by 29% by 2025 compared to 2009. The decline could boost mortality rates from several types of cancer and leave rural areas especially vulnerable to a shortage of urologic surgeons.

Findings from a 15-year retrospective chart review of men treated for recalcitrant post-prostatectomy bladder neck contracture and incontinence can provide insight for urologists on expected outcomes for this challenging population.